Detalles de la búsqueda
1.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol
; 200(2): 175-186, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36214090
2.
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Br J Haematol
; 198(3): 535-544, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35438802
3.
Protective role of melatonin in breast cancer: what we can learn from women with blindness.
Cancer Causes Control
; 33(1): 1-13, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34837156
4.
Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes.
Haematologica
; 104(3): 497-504, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287621
5.
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group.
Cancer
; 124(14): 2956-2963, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29723417
6.
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
Br J Haematol
; 181(3): 350-359, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611196
7.
Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.
Eur J Haematol
; 2018 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29719933
8.
Adherence and patients' attitudes to oral anticancer drugs: a prospective series of 201 patients focusing on targeted therapies.
Oncology
; 88(1): 1-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25247774
9.
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
Blood
; 117(2): 403-11, 2011 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-20940414
10.
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice.
EJHaem
; 4(3): 779-791, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601853
11.
First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia.
Leuk Res
; 130: 107308, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37230027
12.
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.
Clin Exp Med
; 23(3): 803-813, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953763
13.
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.
Br J Haematol
; 158(2): 232-237, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571447
14.
Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level.
Ann Hematol
; 91(1): 39-46, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21553011
15.
A New Modality for Breast Cancer Diagnosis During the COVID-19 Pandemic: A Case Report.
Eur J Breast Health
; 18(1): 91-93, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35059597
16.
Innovative approach to lymphadenectomy in breast sarcoma.
Bull Cancer
; 109(10): 1017-1028, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717223
17.
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis.
Br J Haematol
; 175(5): 975-979, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26773632
18.
New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Eur J Breast Health
; 17(4): 302-307, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651107
19.
Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey.
Eur J Breast Health
; 17(2): 188-196, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870120
20.
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
Blood
; 122(13): 2286-8, 2013 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-24072851